Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma

Ítems similars

• IMMU-34. A BALANCED TRYPTOPHAN DIET LEADS TO MAXIMAL IMMUNOTHERAPEUTIC EFFICACY IN GLIOBLASTOMA MODELS
  per: Ladomersky, Erik, et al.
  Publicat: (2018)
• IMMU-46. GLIOBLASTOMA PATIENT DIAGNOSES AND IMMUNOSUPPRESSION ARE MAXIMAL DURING OLD AGE: A RANDOM COINCIDENCE, OR CAUSE AND EFFECT?
  per: Ladomersky, Erik, et al.
  Publicat: (2018)
• IMMU-35. PSYCHOSOCIAL STRESS NEGATIVELY IMPACTS IMMUNOTHERAPY IN IMMUNOCOMPETENT MODELS OF GLIOBLASTOMA
  per: Ladomersky, Erik, et al.
  Publicat: (2018)
• IMMU-10. RADIOTHERAPY AND PD-1 BLOCKADE INCREASES TRYPTOPHAN METABOLISM IN BRAIN TUMOR-DRAINING SECONDARY LYMPHOID ORGANS
  per: Savoor, Rohan, et al.
  Publicat: (2018)
• HOUT-10. SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL AMONG ELDERLY PATIENTS DIAGNOSED WITH GLIOBLASTOMA
  per: Otto-Meyer, Sebastian, et al.
  Publicat: (2018)